Q.What is the ProFound Breast Health Suite?
A.It's an AI-powered suite from iCAD offering tools for cancer detection, density assessment, and risk evaluation.
I
icadmed.com
★4.3
💬1632
💲Paid
iCAD delivers AI-powered healthcare solutions that support early cancer detection and improved diagnostic accuracy. Its ProFound Breast Health Suite enhances mammography with advanced AI tools, enabling radiologists to detect invasive cancers earlier, streamline workflows, and provide consistent, data-driven assessments of breast density and risk.
💻
Platform
web
AI-powered MammogramsArtificial IntelligenceBreast HealthCancer DetectionDensity AssessmentHealthcare TechnologyMammography
What is icadmed.com?
iCAD is a global leader in AI-powered breast and colon health solutions, designed to enhance early cancer detection and risk assessment. Their ProFound Breast Health Suite offers tools for cancer detection, density scoring, and personalized risk evaluation, backed by clinical evidence. It helps radiologists improve accuracy, reduce reading time, and standardize assessments, ultimately improving patient outcomes.
Core Technologies
- Artificial Intelligence
- Medical Imaging
- AI-powered Mammograms
- Risk Evaluation
- Density Assessment
Key Capabilities
- AI-driven cancer detection
- Automated density scoring
- Personalized risk assessment
- Clinical decision support
- Workflow integration
Use Cases
- Early breast cancer screening
- Breast density analysis
- High-risk patient identification
- Radiology workflow optimization
Core Benefits
- Improved cancer detection accuracy
- Reduced radiologist workload
- Standardized breast density scoring
- More informed treatment planning
- Proven clinical effectiveness
Key Features
- AI-powered cancer detection
- Density assessment
- Risk evaluation
- Seamless workflow integration
- Flexible deployment options
How to Use
- 1Integrate the ProFound Breast Health Suite into existing radiology systems
- 2Use AI tools during mammogram analysis for enhanced detection
- 3Generate objective density scores and risk assessments
- 4Review results and apply insights to patient care plans
Frequently Asked Questions
Q.Is ProFound AI Risk FDA Cleared?
A.No, it’s CE Marked and Health Canada Licensed but only available in the US for investigational use.
Q.How does iCAD improve breast cancer detection?
A.By helping radiologists find more invasive cancers earlier and reducing reading time through AI assistance.
Q.What are the benefits of using ProFound AI for density assessment?
A.It provides objective, reliable, and consistent density scoring, leading to more standardized and accurate evaluations.
Q.Are iCAD products available globally?
A.Some products may not be available in all regions due to regulatory or logistical factors.
Pros & Cons (Reserved)
✓ Pros
- Improves cancer detection accuracy
- Reduces radiologists' reading time
- Provides consistent density scoring
- Offers more accurate risk evaluation than traditional methods
- Supported by clinical evidence
✗ Cons
- ProFound AI Risk not FDA Cleared
- Products may not be available in all regions
- Requires system integration
Alternatives
No alternatives found.